CURIS, INC. Paid-in-Kind Interest
CURIS, INC. (CRIS) reported Paid-in-Kind Interest of -$713.97 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2015-02-24
- CURIS, INC. paid-in-kind interest for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. paid-in-kind interest for the quarter ending 2014-09-30 was -$2.62K.
- CURIS, INC. paid-in-kind interest for the quarter ending 2014-06-30 was -$357.73K, a 245.28% decline year-over-year.
- CURIS, INC. paid-in-kind interest for the quarter ending 2014-03-31 was -$353.62K, a 205.30% decline year-over-year.
- CURIS, INC. paid-in-kind interest for fiscal 2014 was -$713.97K, a 200.00% decline from fiscal 2013.
- CURIS, INC. paid-in-kind interest for fiscal 2013 was $713.97K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 9 month as first filed | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$2.62K derived: sum of 2 quarters · filed 2015-02-24 | -$360.35K derived: sum of 3 quarters · filed 2015-02-24 | -$713.97K 10-K · filed 2015-02-24 | |
| 2014-09-30 | -$2.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$360.35K derived: sum of 2 quarters · filed 2014-11-10 | -$713.97K 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-06-30 | -$357.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$711.35K 10-Q · filed 2014-08-07 | $2.62K derived: sum of 3 quarters · filed 2015-02-24 | -$579.45K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-03-31 | -$353.62K 10-Q · filed 2014-05-09 | $360.35K derived: sum of 2 quarters · filed 2015-02-24 | -$221.71K derived: sum of 3 quarters · filed 2015-02-24 | $24.52K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-12-31 | $713.97K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $131.91K derived: sum of 2 quarters · filed 2015-02-24 | $378.14K derived: sum of 3 quarters · filed 2015-02-24 | $713.97K 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$582.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$335.83K derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $753.64K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $246.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $582.06K 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $335.83K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |